<DOC>
	<DOCNO>NCT02230956</DOCNO>
	<brief_summary>This study evaluate efficacy safety single intra-articular injection 2 dos BOTOX® ( onabotulinumtoxinA ) compare placebo treatment knee osteoarthritis symptom .</brief_summary>
	<brief_title>BOTOX® Efficacy Safety Treatment Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Painful osteoarthritis Able discontinue antiinflammatory drug analgesic Must ambulatory without assistive walking device Chronic pain condition knee osteoarthritis Treatment corticosteroid study knee within 12 week Treatment hyaluronic acid study knee within 24 week Previous treatment botulinum toxin reason Diagnosis myasthenia gravis , EatonLambert syndrome , amyotrophic lateral sclerosis</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>